Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Other Operating Expenses: 2013-2020

Historic Other Operating Expenses for Viridian Therapeutics, Inc.\DE (VRDN) over the last 5 years, with Dec 2020 value amounting to $69.9 million.

  • Viridian Therapeutics, Inc.\DE's Other Operating Expenses rose 332.31% to $453,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $71.3 million, marking a year-over-year decrease of 1.27%. This contributed to the annual value of $69.9 million for FY2020, which is N/A change from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Other Operating Expenses of $69.9 million as of FY2020, which was up 3,529.60% from -$2.0 million recorded in FY2016.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Other Operating Expenses peaked at $69.9 million during FY2020, and registered a low of -$2.0 million during FY2016.
  • Its 1-year average for Other Operating Expenses is $69.9 million, with a median of $69.9 million in 2020.
  • Data for Viridian Therapeutics, Inc.\DE's Other Operating Expenses shows a maximum YoY tumbled of 140.49% (in 2016) over the last 5 years.
  • Viridian Therapeutics, Inc.\DE's Other Operating Expenses (Yearly) stood at -$2.0 million in 2016, then followed by $69.9 million in 2020.